Probenecid

A to Z Drug Facts

Probenecid

  Action
  Indications
  Contraindications
  Route/Dosage
  Interactions
  Lab Test Interferences
  Adverse Reactions
  Precautions
Patient Care Considerations
  Administration/Storage
  Assessment/Interventions
  Patient/Family Education


(pro-BEN-uh-sid)
Class: Analgesic/Gout/Uricosuric

 Action Inhibits tubular reabsorption of urate, thus increasing urinary excretion of uric acid. Inhibits tubular secretion of most penicillin and cephalosporin antibiotics.

 Indications Treatment of hyperuricemia associated with gout and gouty arthritis; adjunctive therapy with penicillins or cephalosporins to elevate and prolong serum levels.

 Contraindications Children < 2 yr; blood dyscrasias or uric acid kidney stones. Do not start therapy until acute gout attack subsides.

 Route/Dosage

Gout

ADULTS & CHILDREN > 110 LB: PO 250 mg bid initially (for 1 wk), followed by 500 mg bid. Maintenance: May reduce by 500 mg q 6 mo until serum uric acid increases.

In Conjunction with Antibiotic Therapy: PO 2 g/day in divided doses. CHILDREN 2 to 14 YR (< 110 LB): PO 25 mg/kg or 0.7 g/m2 initially. Maintenance: 40 mg/kg/day or 1.2 g/m2, divided into 4 doses.

 Interactions Interacts with many other drugs by altering their clearance and elimination.

Barbiturate anesthetics, dyphylline, methotrexate, oral hypoglycemic agents, zidovudine: Increased serum levels and effects of these drugs. Salicylates: Inhibition of uricosuric effect of either drug.

 Lab Test Interferences May produce false-positive results for glycosuria in some urine glucose tests and falsely high assays for theophylline with Schack and Waxler technique. May inhibit renal excretion of phenosulfophthalein, 17-ketosteroids and sulfobromophthalein.

 Adverse Reactions

CNS: Headaches; dizziness. DERM: Dermatitis; pruritus. GI: Anorexia; nausea; GI distress; vomiting; sore gums. GU: Urinary frequency; hematuria; renal colic; nephrotic syndrome. HEMA: Anemia; hemolytic anemia (possibly related to G-6-PD deficiency); aplastic anemia. HEPA: Hepatic necrosis. OTHER: Hypersensitivity reactions; anaphylaxis; fever; flushing; exacerbation of gout; uric acid stones; costovertebral pain.

 Precautions

Pregnancy: Pregnancy category undetermined. Probenecid crosses placenta and appears in cord blood. Children: Not recommended for children < 2 yr. Alkalinization of urine: May be needed to prevent hematuria, renal colic, costovertebral pain, formation of uric acid stones. Exacerbation of gout: May occur; appropriate drug therapy (eg, colchicine or other appropriate therapy) is advisable. History of peptic ulcer: Use with caution. Hypersensitivity: Severe allergic reactions and anaphylaxis, although rare, have occurred. These have usually been associated with prior probenecid use. Renal impairment: May require increased doses for gout (not to exceed 2 g/day). Probenecid may be ineffective in chronic renal insufficiency (ie, glomerular filtration rate of < 30 ml/min). Drug is not recommended for use with penicillin in cases of known renal impairment.


PATIENT CARE CONSIDERATIONS


 Administration/Storage

 Assessment/Interventions

OVERDOSAGE: SIGNS & SYMPTOMS
  Nausea, vomiting, diarrhea, seizure

 Patient/Family Education

Books@Ovid
Copyright
© 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts